“From researchers’ point of view, the sad reality is that there is little incentive to go into the field and this has been the case for decades. When I completed my clinical training in the late 90s and expressed a desire to work on sickle cell disease, people said: “Why would you enter a field with no funding, no opportunities and no future?””